CKD (n = 82) | Non-CKD (n = 133) | P value | |||
---|---|---|---|---|---|
Sociodemographic | Age (y) | Mean ± SD | 52.9 ± 10.6 | 51.1 ± 12.0 | 0.265* |
Sex | Male Female | 32 (39%) 50 (61%) | 60 (45.1%) 73 (54.9%) | 0.381# | |
Comorbidities | BMI (kg/m2) | Mean ± SD | 33.6 ± 6.0 | 31.1 ± 3.9 | < 0.001* |
Waist circumference (cm) | Mean ± SD | 98.8 ± 15.2 | 79.5 ± 13.3 | 0.530* | |
DM | Yes No | 47 (57.3%) 35 (42.7%) | 26 (19.5%) 107 (80.5%) | < 0.001# | |
Hypertension | Yes No | 55 (67.1%) 27 (32.9%) | 73 (54.9%) 60 (45.1%) | 0.077# | |
Metabolic syndrome | Yes No | 44 (53.7%) 38 (46.3%) | 34 (25.6%) 99 (74.4%) | < 0.001# | |
Laboratory investigations | CBC | TLC (10*3/Ul) | 8.0 ± 2.5 | 6.9 ± 2.3 | 0.001* |
Hb | 10.6 ± 1.4 | 10.8 ± 1.7 | 0.306* | ||
PLts | 271.6 ± 96.4 | 255.4 ± 99.6 | 0.243$ | ||
KFT | Creatinine (mg/dl) | 2.3 ± 1.9 | 0.8 ± 0.1 | < 0.001$ | |
Urea (mg/dl) | 61.2 ± 44.8 | 37.2 ± 10.4 | < 0.001$ | ||
Uric acid (mg/dl) | 5.6 ± 1.7 | 5.1 ± 1.2 | 0.007* | ||
ACR (mg/gm) | 117.7 ± 150.0 | 4.2 ± 7.2 | < 0.001$ | ||
eGFR | 50.9 ± 38.7 | 97.8 ± 28.3 | < 0.001$ | ||
Albuminuria Abnormal Normal | 53 (64.6%) 29 (35.4%) | 0 133 (100%) | < 0.001# | ||
LFT | AST | 39.7 ± 26.3 | 38.0 ± 22.9 | 0.622$ | |
ALT | 31.3 ± 15.5 | 29.8 ± 17.3 | 0.530$ | ||
T. bilirubin | 0.56 ± 0.29 | 0.60 ± 0.33 | 0.382$ | ||
Albumin | 3.5 ± 0.6 | 3.8 ± 0.5 | < 0.001* | ||
Prothrombin activity | 75.8 ± 12.2 | 75.0 ± 10.6 | 0.603* | ||
Lipid profile | Total cholesterol | 237.7 ± 139.8 | 206.4 ± 53.5 | 0.021* | |
Triglycerides | 195.7 ± 73.7 | 192.8 ± 122.3 | 0.845$ | ||
LDL | 115.1 ± 40.3 | 109.8 ± 40.8 | 0.355* | ||
HDL | 38.8 ± 13.4 | 42.2 ± 10.6 | 0.041* | ||
FBS | 115.3 ± 44.9 | 93.6 ± 21.2 | < 0.001* | ||
LDH | 212.3 ± 64.3 | 196.2 ± 49.0 | 0.039* | ||
NFS score | -0.29 ± 2.1 | -1.17 ± 1.7 | 0.001* | ||
FIB-4 score | 1.6 ± 1.3 | 1.5 ± 0.9 | 0.509* |